Abstract |
Twelve anaemic patients on haemodialysis were treated with recombinant human erythropoietin, starting with 72 IU/kg/week. The dose was doubled after 2 weeks until an increase of 2 g/dl of haemoglobin was observed. The effects on various parameters were studied during a 3-month period. Haemoglobin increased from 6.70 +/- 0.74 to 10.49 +/- 1.04 g/dl (mean +/- SD, P less than 0.001), potassium from 5.51 +/- 0.50 to 6.06 +/- 0.65 mmol/l (P less than 0.005), phosphate from 1.78 +/- 0.40 to 2.17 +/- 0.40 mmol/l (P less than 0.001) and the calcium phosphorus product from 4.3 to 5.2 (P less than 0.001). Three patients developed marked periarticular inflammation due to calcified deposits with a high calcium- phosphorus product of 6.8. An increase in arterial blood pressure was observed in three previously well-controlled hypertensive patients, one of whom developed hypertensive encephalopathy. We conclude that recombinant human erythropoietin is very effective in treating the anaemia of end-stage renal failure on haemodialysis. Regular estimations of serum potassium and phosphate are mandatory. In hypertensive individuals a further increase in blood pressure is possible.
|
Authors | C Zehnder, Z Glück, C Descoeudres, D E Uehlinger, A Blumberg |
Journal | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
(Nephrol Dial Transplant)
Vol. 3
Issue 5
Pg. 657-60
( 1988)
ISSN: 0931-0509 [Print] England |
PMID | 3146724
(Publication Type: Journal Article)
|
Chemical References |
- Hemoglobins
- Phosphates
- Recombinant Proteins
- Erythropoietin
|
Topics |
- Adult
- Aged
- Anemia
(blood, drug therapy, etiology)
- Erythropoietin
(administration & dosage, adverse effects, therapeutic use)
- Female
- Hemoglobins
(metabolism)
- Humans
- Kidney Failure, Chronic
(complications)
- Male
- Middle Aged
- Periarthritis
(blood, chemically induced)
- Phosphates
(blood)
- Recombinant Proteins
(administration & dosage, adverse effects, therapeutic use)
- Renal Dialysis
|